Kawasaki MATCH Trial

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-17
SponsorUniversity of California, San Diego

About this trial

Evaluating the impact of a machine-learning clinical decision support tool on provider practice when evaluating febrile patients with Kawasaki Disease (KD) and non-KD illnesses.

Eligibility criteria

Qualifiers

Measured or subjective fever for >= 3 calendar days

One measured fever >= 38.0 C (home or in ED)

Rash

Conjunctival injection

Disqualifiers

Congenital or Acquired Immune function

Genetic disorders

Current systemic steroid, immunosuppression, or chemotherapy treatment (not including inhaled steroids)

Trial design

Treatments tested in this trial

  • Kawasaki MATCH

Treatment groups

200 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of California, San Diego

Lead sponsor

Gordon and Marilyn Macklin Foundation

Collaborator

Rady Children's Hospital, San Diego

Collaborator